The global Blood Ketone Meter Market Growth Accelerated by Rising Diabetes Prevalence
Blood ketone meters are medical devices used to monitor ketone levels in the blood and serve as a reliable indicator of diabetic ketoacidosis. Used extensively by diabetic patients for self-monitoring of ketone levels at home, blood ketone meters offer accurate results within 5 seconds and help manage hyperglycemia.
The
global Blood Ketone Meter Market is estimated to be valued at US$ 365.8 Mn in
2023 and is expected to exhibit a CAGR
of 6.9% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of diabetes among the global population has been a
key growth driver for the blood ketone meter market. It is estimated that over
460 million people worldwide currently suffer from diabetes and this figure is
expected to rise to around 700 million by 2045. Frequent self-monitoring of
blood ketone levels helps diabetic patients manage their condition more
effectively and take timely measures to avert medical emergencies. This has significantly
boosted the demand for easy-to-use and cost-effective blood ketone meters in
home settings over the past few years. Market leaders are increasingly focusing
on developing smart blood ketone meters integrated with data transmission
capabilities and smartphone applications for remote monitoring of ketone
levels. This is expected to further accelerate the market's growth during the
forecast period.
Segment Analysis
The global
blood ketone meter market size is dominated by one segment- handheld
ketone meters. These meters are small, portable devices that allow users to
easily test their blood ketone levels at home or anywhere using a small blood
sample. They are ideal for monitoring ketosis levels by diabetics, athletes,
and people following low carb or ketogenic diets. Their affordability and ease
of use has made them the top choice for most consumers in the market.
Key Takeaways
The global blood ketone meter market is expected to witness high growth
over the forecast period of 2023 to 2030.
Europe
currently dominates the market due to rising popularity of keto diets and
increasing incidence of diabetes in the region. However, Asia Pacific is poised
to grow at the fastest rate owing to improving access to healthcare facilities
and rising disposable incomes in developing countries like India and China.
Key players operating in the blood ketone meter market are Abbott Laboratories,
ACON Laboratories Inc., Nipro Corporation, Keto-Mojo, PortaCheck Inc., Nova
Biomedical, GlucoRx Limited, EKF Diagnostics Holdings Plc., Taidoc Technology
Corporation, ForaCare Inc., Bruno MD, and Apex Biotechnology Corporation. These
companies are focusing on developing advanced technologies to provide accurate,
fast and convenient testing solutions. For example, portable Bluetooth-enabled
meters that can pair with smartphones are gaining popularity. Companies are
also expanding to emerging markets through acquisitions and partnerships to
bolster their global footprint. Overall, the market is expected to see positive
growth over the forecast period driven by the rising popularity of ketogenic
diets worldwide.
Get
more insights on this topic: https://www.newsstatix.com/blood-ketone-meter-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment